ESKONAD NEW is a combination of two potent drugs acting synergically. the pseudoephedrine HCl a nasal and sinus decongestant, and the chlorpheniramine maleate (H1 Histamine receptor antagonist).
Pseudoephedrine HCl is a sympathomimetic agent with a long lasting and practically less side effects. It is a vasoconstrictor with decongestant action on nasal and upper respiratory tract mucosal membranes.
Chlorpheniramine maleate is an efficient antihistamine with anticholinergic (drying) effects, well tolerated with excellent effects on rhinorrhea (runny nose), lacrimation, itchy and watery eyes, ocular and nasal pruritus and mucosal membranes edema.
ESKONAD NEW is indicated in the symptomatic relief of congestion and hypersecretion in the nasal cavity and paranasal sinuses, associated with the common cold, allergic rhinitis, acute and chronic rhinitis, sinusitis, sneezing and influenza.
Aleppo Pharmaceutical Company (ALPHA) is Syria's leading
manufacturer and distributor of pharmaceutical products. Providing high
quality products according to GMP requirements; regulations and ISO 9002
(Quality Management System).
Syrian Pharmaceutical Industries, Middle East, Syria Pharmaceutical
Industry, pharmacy, Medicaments, medical, Drugs, arab pharmaceutical
manufacturing, pharmaceutical companies, pharmaceutical sales.
If you have any questions about ESKONAD NEW that have not been
answered on this site send us an email or call ALPHA Pharmaceutical
Industry at + 963-21-2122424.
Copyright © ALPHA – Aleppo Pharmaceutical Industries, Aleppo-Syria -
ESKONAD NEW. All rights reserved
Web Design by
Syrian Web Solutions